1832 Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,664,321
Closed -$100M 694
2017
Q2
$100M Buy
1,664,321
+10,364
+0.6% +$614K 0.45% 55
2017
Q1
$115M Sell
1,653,957
-740,138
-31% -$51.4M 0.41% 59
2016
Q4
$159M Hold
2,394,095
0.49% 57
2016
Q3
$158M Buy
2,394,095
+46,296
+2% +$3.17M 0.6% 44
2016
Q2
$171M Sell
2,347,799
-459,401
-16% -$31.6M 0.67% 42
2016
Q1
$308M Buy
2,807,200
+418,327
+18% +$27.8M 0.75% 38
2015
Q4
$173M Buy
2,388,873
+347,937
+17% +$25.7M 0.75% 38
2015
Q3
$157M Sell
2,040,936
-274,000
-12% -$22.1M 0.66% 43
2015
Q2
$171M Sell
2,314,936
-191,700
-8% -$13.8M 0.58% 45
2015
Q1
$182M Sell
2,506,636
-996,247
-28% -$69.3M 0.68% 40
2014
Q4
$231M Sell
3,502,883
-626,158
-15% -$38.2M 0.72% 35
2014
Q3
$227M Buy
4,129,041
+514,595
+14% +$29.2M 0.74% 34
2014
Q2
$210M Buy
3,614,446
+444,174
+14% +$26.1M 0.66% 38
2014
Q1
$195M Sell
3,170,272
-557,700
-15% -$32.4M 0.67% 43
2013
Q4
$199M Buy
3,727,972
+22,600
+0.6% +$1.21M 0.77% 34
2013
Q3
$186M Hold
3,705,372
0.82% 35
2013
Q2
$170M Buy
+3,705,372
New +$166M 0.74% 34

Other funds holding MD

1832 Asset Management's MD Position: Q3 2017 in Review

1832 Asset Management sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 1,664,321 shares — an estimated $100M sold.

1832 Asset Management first reported a position in MD in Q2 2013 and held it in 17 quarters. The position peaked at $308M in Q1 2016. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

  • 1832 Asset Management reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
  • 1832 Asset Management sold 1,664,321 Pediatrix Medical shares in Q3 2017, an estimated $100M.
  • 1832 Asset Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 17 quarters.
  • 1832 Asset Management's Pediatrix Medical position peaked at $308M in Q1 2016.
  • 337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on 1832 Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.